Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
Journal Article
Kountouras, J., Polyzos S. A., & Deretzi G. (2015).  Helicobacter pylori Associated With Obstructive Sleep Apnea Might Contribute to Sleep, Cognition, and Driving Performance Disturbances in Patients With Cirrhosis.. Clin Gastroenterol Hepatol. 13(8), 1547.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  Helicobacter pylori and insulin resistance association: not just a myth, not yet a fact.. Saudi J Gastroenterol. 17(6), 425-6.
Kountouras, J., Kapetanakis N., Zavos C., Polyzos S. A., Vardaka E., Katsinelos P., et al. (2014).  Helicobacter pylori and colorectal cancer risk--letter.. Cancer Epidemiol Biomarkers Prev. 23(2), 365.
Kountouras, J., Zavos C., Polyzos S. A., & Deretzi G. (2015).  The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems.. Ann Gastroenterol. 28(4), 506.
Kountouras, J., Kazakos E., Polyzos S. A., Chatzopoulos D., Tzitiridou-Chatzopoulou M., Doulberis M., et al. (2022).  GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection.. Helicobacter. 27(3), e12884.
Kountouras, J., Doulberis M., Papaefthimiou A., & Polyzos S. A. (2019).  Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine.. Ann Gastroenterol. 32(3), 318.
Anastasilakis, A. D., Koulaxis D., Upadhyay J., Pagkalidou E., Kefala N., Perakakis N., et al. (2019).  Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls.. Horm Metab Res. 51(2), 112-119.
Anastasilakis, A. D., Makras P., Polyzos S. A., & Papapoulos S. E. (2023).  The Five-Year Effect of a Single Zoledronate Infusion on Bone Mineral Density Following Denosumab Discontinuation in Women with Postmenopausal Osteoporosis.. Calcif Tissue Int.
Seo, Y-G., Polyzos S. A., Park K-H., & Mantzoros C. S. (2023).  Fibrosis-4 index predicts long-term all-cause, cardiovascular and liver-related mortality in the adult Korean population.. Clin Gastroenterol Hepatol.
Raptis, D. D., Mantzoros C. S., & Polyzos S. A. (2023).  Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease.. Ther Clin Risk Manag. 19, 77-96.
Dalamaga, M., Polyzos S. A., Karmaniolas K., Chamberland J., Lekka A., Triantafilli M., et al. (2016).  Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study.. Leuk Lymphoma. 57(3), 577-84.
Polyzos, S. A., Perakakis N., & Mantzoros C. S. (2019).  Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.. Metabolism. 96, 66-82.
Venetsanaki, V., Karabouta Z., & Polyzos S. A. (2019).  Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis.. Eur J Pharmacol. 863, 172661.
Franceschi, F., Gasbarrini A., Polyzos S. A., & Kountouras J. (2015).  Extragastric Diseases and Helicobacter pylori.. Helicobacter. 20 Suppl 1, 40-6.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Zavos C., & Doulberis M. (2020).  Erratum to: Letter to the editor re: Li et al. (2020), 'The potential role of bacteria in pancreatic cancer: A systematic review'.. Carcinogenesis.
Kountouras, J., Zavos C., Polyzos S. A., Katsinelos P., & Stergiopoulos C. (2014).  Eradication of Helicobacter pylori infection might have a positive impact on subpopulations with endoscopic gastro-oesophageal reflux disease.. Eur J Gastroenterol Hepatol. 26(1), 123.
Makri, E., Goulas A., & Polyzos S. A. (2021).  Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease.. Arch Med Res. 52(1), 25-37.
Polyzos, S. A., & Kountouras J. (2020).  Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitis.. Ann Hepatol. 19(5), 579-580.
Anastasilakis, A. D., Polyzos S. A., Goulis D. G., Slavakis A., Efstathiadou Z., Kita M., et al. (2008).  Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis.. Endocr J. 55(3), 613-6.
Polyzos, S. A. (2017).  Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 89-91.
Kountouras, J., Doulberis M., Polyzos S. A., Kazakos E., Vardaka E., Tzitiridou-Chatzopoulou M., et al. (2022).  Emerging parameters relevant to the management of antimicrobial-resistant Helicobacter pylori infection.. Intern Med J. 52(9), 1654-1655.
Mintziori, G., & Polyzos S. A. (2016).  Emerging and future therapies for nonalcoholic steatohepatitis in adults.. Expert Opin Pharmacother. 17(14), 1937-46.
Anastasilakis, A. D., Polyzos S. A., Makras P., Trovas G., Yavropoulou M. P., & Tournis S. (2021).  Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation.. J Clin Densitom.
Polyzos, S. A., Kountouras J., Mantzoros C. S., Polymerou V., & Katsinelos P. (2017).  Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.. Diabetes Obes Metab. 19(12), 1805-1809.
Kountouras, J., Gavalas E., Doulberis M., Polyzos S. A., Papaefthimiou A., Touloumtsi M., et al. (2019).  The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders.. J Neurogastroenterol Motil.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.